Cargando…

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

BACKGROUND: Maternal-infant transmission of hepatitis B virus(HBV) occurs even after passive-active immunization. Some scholars speculate that in-utero infection may be the main cause of immunoprophylaxis failure. However, there is a lack of evidence about the possible occurrence periods of perinata...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Gui, Xi-En, Wang, Bo, Fan, Jing-Yi, Cao, Qian, Mullane, Kathleen, Liang, Xiao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982401/
https://www.ncbi.nlm.nih.gov/pubmed/27515176
http://dx.doi.org/10.1186/s12879-016-1754-1
_version_ 1782447773946216448
author Zhang, Lei
Gui, Xi-En
Wang, Bo
Fan, Jing-Yi
Cao, Qian
Mullane, Kathleen
Liang, Xiao-Li
author_facet Zhang, Lei
Gui, Xi-En
Wang, Bo
Fan, Jing-Yi
Cao, Qian
Mullane, Kathleen
Liang, Xiao-Li
author_sort Zhang, Lei
collection PubMed
description BACKGROUND: Maternal-infant transmission of hepatitis B virus(HBV) occurs even after passive-active immunization. Some scholars speculate that in-utero infection may be the main cause of immunoprophylaxis failure. However, there is a lack of evidence about the possible occurrence periods of perinatal transmission. METHODS: From 2008 to 2012, 428 pairs of HBsAg-positive mothers and neonates were enrolled and 385 infants aged 8–12 months were followed. HBV markers (HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc, HBV-DNA) were performed on all subjects. RESULTS: Of mothers who were positive for HBsAg, HBeAg, HBV-DNA, 35.1 %, 94.3 %, 12.7 % of their neonates were positive for those indices, respectively. Neonates’ mean titers of those indices were significantly lower than their mothers’. There were no significant differences in rates of positivity and mean titers of anti-HBe and anti-HBc between neonates and mothers. Most of the positive indices turned negative during the follow-up period. Immunoprophylaxis failed in seventeen infants: four infants had HBV-DNA > 6 log (10)copies/mL both at birth and in follow-up; in six infants, mean viral load was 3.72 ± 0.17 log (10)copies/mLat birth and 7.62 ± 0.14 log (10)copies/mL at follow-up; seven infants were HBV-DNA negative at birth but were found to have > 6 log (10)copies/mL during follow-up. Infants that were immunoprophylaxis failures were all born to HBeAg-positive mothers with HBV-DNA > 6 log (10)copies/mL. CONCLUSIONS: The placental barrier can partly prevent maternal HBsAg, HBeAg, HBV-DNA from passing through to fetus. Performing HBsAg, HBeAg, HBV-DNA once at birth can neither diagnose nor exclude maternal-infant transmission. The diagnosis of infection period depends on the dynamic changes in viral load from birth through the follow-up period but whether the infection occurred in utero, at delivery or during the neonatal period could not be determined.
format Online
Article
Text
id pubmed-4982401
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49824012016-08-19 Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates Zhang, Lei Gui, Xi-En Wang, Bo Fan, Jing-Yi Cao, Qian Mullane, Kathleen Liang, Xiao-Li BMC Infect Dis Research Article BACKGROUND: Maternal-infant transmission of hepatitis B virus(HBV) occurs even after passive-active immunization. Some scholars speculate that in-utero infection may be the main cause of immunoprophylaxis failure. However, there is a lack of evidence about the possible occurrence periods of perinatal transmission. METHODS: From 2008 to 2012, 428 pairs of HBsAg-positive mothers and neonates were enrolled and 385 infants aged 8–12 months were followed. HBV markers (HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc, HBV-DNA) were performed on all subjects. RESULTS: Of mothers who were positive for HBsAg, HBeAg, HBV-DNA, 35.1 %, 94.3 %, 12.7 % of their neonates were positive for those indices, respectively. Neonates’ mean titers of those indices were significantly lower than their mothers’. There were no significant differences in rates of positivity and mean titers of anti-HBe and anti-HBc between neonates and mothers. Most of the positive indices turned negative during the follow-up period. Immunoprophylaxis failed in seventeen infants: four infants had HBV-DNA > 6 log (10)copies/mL both at birth and in follow-up; in six infants, mean viral load was 3.72 ± 0.17 log (10)copies/mLat birth and 7.62 ± 0.14 log (10)copies/mL at follow-up; seven infants were HBV-DNA negative at birth but were found to have > 6 log (10)copies/mL during follow-up. Infants that were immunoprophylaxis failures were all born to HBeAg-positive mothers with HBV-DNA > 6 log (10)copies/mL. CONCLUSIONS: The placental barrier can partly prevent maternal HBsAg, HBeAg, HBV-DNA from passing through to fetus. Performing HBsAg, HBeAg, HBV-DNA once at birth can neither diagnose nor exclude maternal-infant transmission. The diagnosis of infection period depends on the dynamic changes in viral load from birth through the follow-up period but whether the infection occurred in utero, at delivery or during the neonatal period could not be determined. BioMed Central 2016-08-12 /pmc/articles/PMC4982401/ /pubmed/27515176 http://dx.doi.org/10.1186/s12879-016-1754-1 Text en © Zhang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Lei
Gui, Xi-En
Wang, Bo
Fan, Jing-Yi
Cao, Qian
Mullane, Kathleen
Liang, Xiao-Li
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
title Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
title_full Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
title_fullStr Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
title_full_unstemmed Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
title_short Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
title_sort serological positive markers of hepatitis b virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982401/
https://www.ncbi.nlm.nih.gov/pubmed/27515176
http://dx.doi.org/10.1186/s12879-016-1754-1
work_keys_str_mv AT zhanglei serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates
AT guixien serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates
AT wangbo serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates
AT fanjingyi serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates
AT caoqian serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates
AT mullanekathleen serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates
AT liangxiaoli serologicalpositivemarkersofhepatitisbvirusinfemoralvenousbloodorumbilicalcordbloodshouldnotbeevidenceofinuteroinfectionamongneonates